Carotid Artery Stent Implantation in the Treatment of Vulnerable Plaque
NCT ID: NCT05524207
Last Updated: 2022-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2022-01-01
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Evaluation of Carotid Artery Atherosclerotic Plaques and Recanalization
NCT03786666
Efficacy and Prognosis of Surgical Intervention in Patients With Carotid Artery Stenosis
NCT06222983
The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Intracranial Atherosclerotic Stenosis
NCT05593224
Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting
NCT01654666
Endarterectomy vs Stenting in Chinese Asymptomatic Carotid Stenosis Patients
NCT03737175
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. The investigators divide patients into the stable group and the vulnerable group based on the results of CEUS inspection.
3. All patients undergo carotid stent. To analysis the incidence of postoperative complications such as stroke and mortality within 30 days and to compare the differences between the two groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vulnerable plaque group
Patients with preoperative contrast-enhanced intra-plaque contrast agent were classified as vulnerable plaque group
carotid artery stenting
Implantation of stents at the site of carotid artery stenosis for the treatment of carotid plaque with severe stenosis
Stable plaque group
The patients with no contrast agent enhancement in the plaque showed preoperative contrast-enhanced ultrasound were classified as stable plaque group
carotid artery stenting
Implantation of stents at the site of carotid artery stenosis for the treatment of carotid plaque with severe stenosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
carotid artery stenting
Implantation of stents at the site of carotid artery stenosis for the treatment of carotid plaque with severe stenosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients without ischemic symptom whose carotid stenosis were more than 70%
Exclusion Criteria
* Suffering from the large area cerebral infarction or critical stroke sequela
* Restenosis after CEA or CAS
* Suffering from severe coronary heart disease, respiratory failure,the hypertension difficult to controled
* Patients with malignant tumor or expected life \< 2 years
20 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tsinghua Chang Gung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keqiang Zhao
Attending Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
sifan yang
Role: STUDY_DIRECTOR
Beijing Tsinghua Chang Gung Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tsinghua Chang Gung Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
weiwei wu, M.D.
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20220816
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.